| Breakdown | Mar 2026 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 624.30M | 601.10M | 570.90M | 500.20M | 262.80M |
| Gross Profit | 470.60M | 601.10M | 450.30M | 347.10M | 256.50M |
| EBITDA | 412.00M | 397.90M | 366.90M | 308.50M | 167.00M |
| Net Income | 293.90M | 282.60M | 256.90M | 233.90M | 127.80M |
Balance Sheet | |||||
| Total Assets | 685.30M | 639.60M | 658.00M | 662.70M | 534.50M |
| Cash, Cash Equivalents and Short-Term Investments | 18.20M | 15.30M | 18.70M | 16.60M | 45.70M |
| Total Debt | 206.00M | 3.50M | 34.60M | 68.70M | 35.10M |
| Total Liabilities | 278.20M | 70.20M | 105.70M | 135.40M | 75.80M |
| Stockholders Equity | 407.10M | 569.40M | 552.30M | 527.30M | 458.70M |
Cash Flow | |||||
| Free Cash Flow | 298.90M | 300.60M | 283.70M | 263.40M | 120.30M |
| Operating Cash Flow | 326.20M | 304.60M | 287.50M | 266.80M | 121.70M |
| Investing Cash Flow | -22.90M | 1.60M | 1.80M | -129.60M | -11.40M |
| Financing Cash Flow | -300.40M | -309.60M | -283.80M | -171.90M | -102.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | £3.29B | 18.49 | 264.68% | 1.65% | 9.04% | 14.80% | |
71 Outperform | £3.69B | 6.75 | 60.53% | 1.81% | 3.86% | 9.38% | |
68 Neutral | £823.65M | 15.59 | 13.93% | 1.69% | 9.55% | 29.82% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% |